NASDAQ:LHCG - Nasdaq - US50187A1079 - Common Stock - Currency: USD
169.81
+0.8 (+0.47%)
The current stock price of LHCG is 169.81 USD. In the past month the price increased by 3.28%. In the past year, price increased by 25.82%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CVS | CVS HEALTH CORP | 11.22 | 90.02B | ||
CI | THE CIGNA GROUP | 10.85 | 81.35B | ||
LH | LABCORP HOLDINGS INC | 18.32 | 23.05B | ||
DGX | QUEST DIAGNOSTICS INC | 19.48 | 20.61B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 12.38 | 14.82B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 110.68 | 14.45B | ||
DVA | DAVITA INC | 14.22 | 10.40B | ||
HIMS | HIMS & HERS HEALTH INC | 53.74 | 9.62B | ||
GH | GUARDANT HEALTH INC | N/A | 7.29B | ||
CHE | CHEMED CORP | 20.43 | 6.68B | ||
RDNT | RADNET INC | 190.61 | 5.28B | ||
CRVL | CORVEL CORP | 48.92 | 4.57B |
LHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company is headquartered in Lafayette, Louisiana and currently employs 16,000 full-time employees. The company went IPO on 2005-06-09. The firm operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services and Healthcare Innovations (HCI). The Home Health Service segment offers a range of services, including wound care and dressing changes, pain management, pharmaceutical administration, skilled observation and assessment and patient education. The Hospice segment offers a range of services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The Home and Community-Based Services segment, services are performed by skilled nursing and paraprofessional personnel, and include assistance with activities of daily living to the elderly, chronically ill, and disabled patients. HCI segment reports on its developmental activities outside its other business segments.
LHC GROUP INC
901 Hugh Wallis Road South
Lafayette LOUISIANA 70508 US
CEO: Keith G. Myers
Employees: 16000
Phone: 13372331307.0
The current stock price of LHCG is 169.81 USD. The price increased by 0.47% in the last trading session.
The exchange symbol of LHC GROUP INC is LHCG and it is listed on the Nasdaq exchange.
LHCG stock is listed on the Nasdaq exchange.
13 analysts have analysed LHCG and the average price target is 176.8 USD. This implies a price increase of 4.12% is expected in the next year compared to the current price of 169.81. Check the LHC GROUP INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
LHC GROUP INC (LHCG) has a market capitalization of 5.27B USD. This makes LHCG a Mid Cap stock.
LHC GROUP INC (LHCG) currently has 16000 employees.
LHC GROUP INC (LHCG) has a support level at 168.28 and a resistance level at 169.82. Check the full technical report for a detailed analysis of LHCG support and resistance levels.
The Revenue of LHC GROUP INC (LHCG) is expected to grow by 4.9% in the next year. Check the estimates tab for more information on the LHCG EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
LHCG does not pay a dividend.
LHC GROUP INC (LHCG) will report earnings on 2023-05-02.
The PE ratio for LHC GROUP INC (LHCG) is 38.68. This is based on the reported non-GAAP earnings per share of 4.39 and the current share price of 169.81 USD. Check the full fundamental report for a full analysis of the valuation metrics for LHCG.
ChartMill assigns a technical rating of 7 / 10 to LHCG. When comparing the yearly performance of all stocks, LHCG is one of the better performing stocks in the market, outperforming 87.53% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to LHCG. LHCG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months LHCG reported a non-GAAP Earnings per Share(EPS) of 4.39. The EPS decreased by -25.09% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 2.73% | ||
ROA | 2.16% | ||
ROE | 3.94% | ||
Debt/Equity | 0.46 |
ChartMill assigns a Buy % Consensus number of 52% to LHCG. The Buy consensus is the average rating of analysts ratings from 13 analysts.
For the next year, analysts expect an EPS growth of -22.68% and a revenue growth 4.9% for LHCG